Transcranial low-level laser therapy enhances learning, memory, and neuroprogenitor cells after traumatic brain injury in mice

Journal of Biomedical Optics

Volumn 19, Issue 10, 2014, Pages

  Xuan, Weijun ^a,c   Vatansever, Fatma ^b,c   Huang, Liyi ^b,c,d   Hamblin, Michael R ^b,c,e  

^a RUIKANG HOSPITAL AFFILIATED TO GUANGXI UNIVERSITY OF CHINESE MEDICINE   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d GUANGXI MEDICAL UNIVERSITY   (China)

^e HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

BrdU; caspase 3; double cortin; TUJ 1; mitochondrial modulation; Morris water maze; NeuN; neurogenesis; transcranial low level light therapy; Traumatic brain injury; wire grip motion test

Indexed keywords

BRAIN; CELL DEATH; HORMONES; MAMMALS; NEUROLOGY; SILICATE MINERALS; WIRE;

BRDU; CASPASE-3; DOUBLE-CORTIN; TUJ-1; LOW-LEVEL-LIGHT; MORRIS WATER MAZE; MOTION TESTS; NEUN; NEUROGENESIS; TRAUMATIC BRAIN INJURIES;

LASER SURGERY;

MUS;

CASP3 PROTEIN, MOUSE; CASPASE 3; FLUORESCEIN DERIVATIVE; FLUORO JADE; NERVE PROTEIN; NEUN PROTEIN, MOUSE; NUCLEAR PROTEIN; TUBULIN;

ANIMAL; ANIMAL BEHAVIOR; BAGG ALBINO MOUSE; BRAIN INJURIES; CYTOLOGY; FLUORESCENCE MICROSCOPY; HIPPOCAMPUS; LOW LEVEL LASER THERAPY; MALE; MAZE TEST; MEMORY; METABOLISM; MOUSE; NERVE CELL; NERVOUS SYSTEM DEVELOPMENT; PATHOPHYSIOLOGY; RADIATION RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; CASPASE 3; FLUORESCEINS; HIPPOCAMPUS; LASER THERAPY, LOW-LEVEL; MALE; MAZE LEARNING; MEMORY; MICE; MICE, INBRED BALB C; MICROSCOPY, FLUORESCENCE; NERVE TISSUE PROTEINS; NEUROGENESIS; NEURONS; NUCLEAR PROTEINS; TUBULIN;

EID: 84911461833     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.JBO.19.10.108003     Document Type: Article

References (46)

1. B. Roozenbeek et al., "Predicting 14-day mortality after severe traumatic brain injury: application of the IMPACT models in the Brain Trauma Foundation TBI-trac(R) New York State database," J. Neurotrauma 29(7), 1306-1312 (2012).
2. R. C. Opreanu, D. Kuhn, and M. D. Basson, "Influence of alcohol on mortality in traumatic brain injury," J. Am. Coll. Surg. 210(6), 997-1007 (2010).
3. J. Dubourg and M. Messerer, "Sports-related chronic repetitive head trauma as a cause of pituitary dysfunction," Neurosurg. Focus 31(5), E2 (2011).
4. K. S. Meyer et al., "Combat-related traumatic brain injury and its implications to military healthcare," Psychiatr. Clin. North Am. 33(4), 783-96 (2010).
5. D. J. Loane and A. I. Faden, "Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies," Trends Pharmacol. Sci. 31(12), 596-604 (2010).
6. H. Chung et al., "The nuts and bolts of low-level laser (light) therapy," Ann. Biomed. Eng. 40(2), 516-533 (2012).
7. M. A. Naeser and M. R. Hamblin, "Potential for transcranial laser or LED therapy to treat stroke, traumatic brain injury, and neurodegenerative disease," Photomed. Laser Surg. 29(7), 443-446 (2011).
8. F. Schiffer et al., "Psychological benefits 2 and 4 weeks after a single treatment with near infrared light to the forehead: a pilot study of 10 patients with major depression and anxiety," Behav. Brain Funct. 5, 46 (2009).
9. Y. Y. Huang et al., "Biphasic dose response in low level light therapy," Dose Response 7(4), 358-383 (2009).
10. T. Ando et al., "Comparison of therapeutic effects between pulsed and continuous wave 810-nm wavelength laser irradiation for traumatic brain injury in mice," PLoS ONE 6(10), e26212 (2011).
11. Q. Wu et al., "Low level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths," Lasers Surg. Med. 44(3), 218-226 (2012).
12. W. Xuan et al., "Transcranial low-level laser therapy improves neurological performance in traumatic brain injury in mice: effect of treatment repetition regimen," PLoS ONE 8(1), e53454 (2013).
13. J. Khuman et al., "Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice," J. Neurotrauma 29, 408-417 (2012).
14. A. Oron et al., "Low-level laser therapy applied transcranially to mice following traumatic brain injury significantly reduces long-term neurological deficits," J. Neurotrauma 24(4), 651-656 (2007).
15. U. Oron, "Near infrared transcranial laser therapy applied at various modes to mice following traumatic brain injury significantly reduces long-term neurological deficits," J. Neurotrauma 29(2), 401-407 (2011).
16. L. Bonfanti and P. Peretto, "Adult neurogenesis in mammals: a theme with many variations," Eur. J. Neurosci. 34(6), 930-950 (2011).
17. C. Zhang et al., "Role of transcription factors in neurogenesis after cerebral ischemia," Rev. Neurosci. 22(4), 457-465 (2011).
18. R. M. Richardson, D. Sun, and M. R. Bullock, "Neurogenesis after traumatic brain injury," Neurosurg. Clin. North Am. 18(1), 169-181 (2007).
19. Y. Mu and F. H. Gage, "Adult hippocampal neurogenesis and its role in Alzheimer's disease," Mol. Neurodegener. 6, 85 (2011).
20. N. D. Hanson, M. J. Owens, and C. B. Nemeroff, "Depression, antidepressants, and neurogenesis: a critical reappraisal," Neuropsychopharmacology 36(13), 2589-2602 (2011).
21. P. Beukelaers et al., "Cycling or not cycling: cell cycle regulatory molecules and adult neurogenesis," Cell Mol. Life Sci. 69(9), 1493-1503 (2012).
22. I. Masiulis, S. Yun, and A. J. Eisch, "The interesting interplay between interneurons and adult hippocampal neurogenesis," Mol. Neurobiol. 44(3), 287-302 (2011).
23. S. Bovetti et al., "From progenitors to integrated neurons: role of neurotransmitters in adult olfactory neurogenesis," J. Chem. Neuroanat. 42(4), 304-316 (2011).
24. K. Bromley-Brits, Y. Deng, and W. Song, "Morris water maze test for learning and memory deficits in Alzheimer's disease model mice," J. Vis. Exp. 53(53), 2920 (2011).
25. F. R. Sharp, J. Liu, and R. Bernabeu, "Neurogenesis following brain ischemia," Brain Res. Dev. Brain Res. 134(1-2), 23-30 (2002).
26. M. Brus, M. Keller, and F. Levy, "Temporal features of adult neurogenesis: differences and similarities across mammalian species," Front. Neurosci. 7, 135 (2013).
27. E. J. Kim et al., "Ascl1 (Mash1) defines cells with long-term neurogenic potential in subgranular and subventricular zones in adult mouse brain," PLoS ONE 6(3), e18472 (2011).
28. L. Zhang et al., "Survivin, a key component of the Wnt/beta-catenin signaling pathway, contributes to traumatic brain injury-induced adult neurogenesis in the mouse dentate gyrus," Int. J. Mol. Med. 32(4), 867-875 (2013).
29. S. Acosta et al., "NT-020, a natural therapeutic approach to optimize spatial memory performance and increase neural progenitor cell proliferation and decrease inflammation in the aged rat," Rejuvenation Res. 13(5), 581-588 (2010).
30. X. Xiao et al., "Neuroprotection and enhanced neurogenesis by tetramethylpyrazine in adult rat brain after focal ischemia," Neurol. Res. 32(5), 547-555 (2010).
31. O. von Bohlen Und Halbach, "Immunohistological markers for staging neurogenesis in adult hippocampus," Cell Tissue Res. 329(3), 409-420 (2007).
32. S. P. Memberg and A. K. Hall, "Dividing neuron precursors express neuron-specific tubulin," J. Neurobiol. 27(1), 26-43 (1995).
33. J. Khuman et al., "Low-level laser light therapy improves cognitive deficits and inhibits microglial activation after controlled cortical impact in mice," J. Neurotrauma 29(2), 408-417 (2012).
34. B. J. Quirk et al., "Near-infrared photobiomodulation in an animal model of traumatic brain injury: improvements at the behavioral and biochemical levels," Photomed. Laser Surg. 30(9), 523-529 (2012).
35. L. De Taboada et al., "Transcranial laser therapy attenuates amyloidbeta peptide neuropathology in amyloid-beta protein precursor transgenic mice," J. Alzheimers Dis. 23(3), 521-535 (2011).
36. S. Couillard-Despres et al., "Doublecortin expression levels in adult brain reflect neurogenesis," Eur. J. Neurosci. 21(1), 1-14 (2005).
37. J. R. Menezes and M. B. Luskin, "Expression of neuron-specific tubulin defines a novel population in the proliferative layers of the developing telencephalon," J. Neurosci. 14(9), 5399-5416 (1994).
38. J. Chu, S. Wu, and D. Xing, "Survivin mediates self-protection through ROS/cdc25c/CDK1 signaling pathway during tumor cell apoptosis induced by high fluence low-power laser irradiation," Cancer Lett. 297(2), 207-219 (2010).
39. Y. Y. Huang et al., "Low-level laser therapy (810 nm) protects primary cortical neurons against excitotoxicity in vitro," J. Biophotonics 7(8), 656-664 (2013).
40. Y. Y. Huang et al., "Low-level laser therapy (LLLT) reduces oxidative stress in primary cortical neurons in vitro," J. Biophotonics 6(10), 829-838 (2013).
41. S. Ghavami, "Autophagy and apoptosis dysfunction in neurodegenerative disorders," Prog. Neurobiol. 112, 24-49 (2014).
42. G. S. Salvesen, "Caspases: opening the boxes and interpreting the arrows," Cell Death Differ. 9(1), 3-5 (2002).
43. S. Ghavami et al., "Apoptosis and cancer: mutations within caspase genes," J. Med. Genet. 46(8), 497-510 (2009).
44. Y. Kaneko et al., "Nestin overexpression precedes caspase-3 upregulation in rats exposed to controlled cortical impact traumatic brain injury," Cell Med. 4(2), 55-63 (2012).
45. N. Ad and U. Oron, "Impact of low level laser irradiation on infarct size in the rat following myocardial infarction," Int. J. Cardiol. 80(2-3), 109-116 (2001).
46. A. Oron et al., "Low-level laser therapy applied transcranially to rats after induction of stroke significantly reduces long-term neurological deficits," Stroke 37(10), 2620-2624 (2006).